Gem Aromatics
- Market cap
- ₹ 713 Cr.
- P/E
- 29.6x
- P/B
- 1.64x
- 52-week range
- 131.02 – 237
- ROE
- 0%
- ROCE
- 3%
- Dividend yield
- 0%
- Debt / equity
- 0.34
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Gem Aromatics Limited is an India-based company engaged in the manufacturing of specialty ingredients, including essential oils, aroma chemicals and derivatives, in India. The Company specializes in offering products that are derived from mint and clove oil. It also offers essential oil-based products and derivatives that are manufactured from eucalyptus oils and other essential oils. The Company offers over 70 products across its four product categories, namely mint and mint derivatives; clove and clove derivatives; phenol; and other synthetic and natural ingredients. It operates three manufacturing facilities all located in India, namely the Budaun Facility, Silvassa Facility, and Dahej Facility. It serves various industries, such as oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management and personal care. Its subsidiaries include Krystal Ingredients Private Limited and Gem Aromatics LLC.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Gem Aromatics against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)29.6 against a typical 26.3: pricier than most peers (1st = cheapest).72nd of 129
- Sales growth+12.8% against a typical +25.9% from a year earlier.87th of 112
- Profit growth−198.6% against a typical +42.4% from a year earlier.100th of 102
- Share price, 3 months−25.4% against a typical −5.5%.113th of 118
- Size₹ 713.1 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).55th of 126
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety, with caution
Rated A+ by Acuite- Acuite expects things to get worse (negative outlook).
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| Acuite | ACUITE A+ | Negative | 1 Jun 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 1 Jun 2026 | ▼ Outlook cut | ACUITE A+ Outlook Stable → Negative | — | Acuite | ₹ 196 Cr. | |
| 10 Oct 2025 | ▲ Upgrade | ACUITE A+ | — | Acuite | ₹ 196 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 31 Oct 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 13 Aug 2026 | Financial Results | To consider and approve the unaudited financial results for the quarter ended June 30, 2026 |
| 21 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 27 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 12 Sep 2025 | Financial Results | To consider and approve the financial results for the period ended June 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 93 | 112 | 97 | 202 | 88 | 90 | 79 | 110 | 99 |
| Expenses | 78 | 97 | 84 | 156 | 73 | 86 | 72 | 95 | 96 |
| Operating Profit | 14 | 15 | 13 | 46 | 15 | 3 | 7 | 16 | 3 |
| OPM % | 15.3% | 13.7% | 13.5% | 22.7% | 17% | 3.4% | 8.9% | 14.2% | 3.3% |
| Other Income | 1 | 1 | 1 | −0 | 1 | 1 | −2 | 0 | 0 |
| Interest | 1 | 1 | 2 | 3 | 4 | 4 | 3 | 3 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 9 | 9 | 9 |
| Profit before tax | 12 | 13 | 9 | 40 | 11 | −3 | −6 | 4 | −9 |
| Tax % | 30.3% | 24.6% | 20.8% | 31.1% | 26% | 2.4% | −15.9% | 74.9% | −7.8% |
| Net Profit | 9 | 10 | 7 | 28 | 8 | −3 | −5 | 1 | −8 |
| EPS in Rs | 1.83 | 2.08 | 1.59 | 5.89 | 1.7 | −0.49 | −0.96 | 0.19 | −1.51 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 4%
- 3 Years
- −5%
- TTM
- −24%
- 10 Years
- —
- 5 Years
- −43%
- 3 Years
- −68%
- TTM
- −127%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 16%
- 3 Years
- 13%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Gem Aromatics | ₹ 141.25 | ₹ 713 Cr. | 29.6x | 1.6x | 0% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Vipul Nathalal Parekh
- Executive Chairman of the Board
- Yash Vipul Parekh
- Chief Executive Officer, Managing Director, Executive Director
- Kaksha Vipul Parekh
- Chief Financial Officer, Whole Time Director
- Akshita Deepak Gohil
- Compliance Officer, Company Secretary
- Dinesh Vasu Thekkepanakkal
- Additional (Whole Time) Director
Prices are delayed and for information only. Nothing on this page is investment advice.